The effectiveness of biomarkers has made them essential to medicine, with successful products on the market and many products in development. This Kalorama Information report focuses on both the clinical biomarkers and research biomarkers in medicine.
Biomarkers are physiologic, genetic or biochemical parameters that provide insight into understanding disease processes and ways that medicines can work to counteract the disease. With them, diseases are detected earlier, more effective treatments can be delivered, drug reactions reduced. An example is creatine kinase, or CK-MB, a marker that facilitates high-energy phosphates in the body’s tissues, and can suggest a cardiovascular event when levels are high. Other markers can identify the seriousness of tumors or signal immune system problems.
These biomarkers are valuable in assessing risk, detecting current disorders or diseases, treatment assessments, drug matching, etc. In research, biomarkers are useful for drug development and determining new markers for drug targeting.
The report will provide a market analysis for five broad areas of medical biomarkers:
The analysis presented in this report is based on data from a combination of company, government, industry, institutional and private sources. It includes information from extensive literature reviews and discussions with experts in the field, including microbiologists, pathologists, hospital authorities, reimbursement specialists, research scientists, business development managers and marketing managers.
All market data are based on factory sales to the end user and not retail pricing or reimbursement payments. Market data pertains to the world market at the manufacturers’ level. The base year for data was 2013. Historical data was provided for the years 2008 through 2012, with forecast data provided for 2014 through 2018. Compound annual growth rates (CAGRs) are provided for the 2008-2013 and 2013-2018 periods for each segment covered.
Basic competitor summaries are included in each segment. The forecasted market analysis for 2014-2018 was largely based on demographic trends, new developments, biomarker development, company performance trends, merger and acquisitions, and global expansion.
Company profiles in this report include:
Related Reports:Surgical Procedure Volumes: Global Analysis (US, China, Japan, Brazil, UK, Germany, Italy, France, Mexico)
Feb 22, 2014 - KLI5205473 - $2,995.00
The Worldwide Market for Respiratory Devices (Inhalers, Nebulizers, Airways, Masks, Sleep Apnea, Oxygen Therapy, Ventilators Medical Humidifiers, Respiratory Measurement)
Jan 23, 2014 - KLI5192151 - $3,995.00
The World Market for Molecular Diagnostics Six Month Update
Jan 14, 2014 - KLI5181507 - $2,995.00
The World Market for Infusion Pumps (Large Volume Pumps, Ambulatory Pumps, Insulin Pumps, Enteral Feeding Pumps, Others)
Jan 6, 2014 - KLI5177834 - $3,995.00
The World Market for Hematology
Nov 22, 2013 - KLI5156915 - $3,995.00
The World Market for Medical Beds
Nov 8, 2013 - KLI5153655 - $3,995.00
The World Market for Immunoassays
Nov 6, 2013 - KLI5146358 - $3,995.00
The World Market for Infectious Disease Diagnostic Tests
Oct 21, 2013 - KLI5137619 - $3,995.00
The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition
Sep 22, 2013 - KLI5123810 - $1,995.00
The World Market for Cloud Computing in Healthcare (Saas, IaaS, PaaS, Other Cloud Markets, Healthcare IT Spending and Other Trends)
Sep 10, 2013 - KLI5114613 - $3,995.00
Questions?Contact a research specialist >
Most Popular ResearchWhy Epigenomics May Be a Game-Changer in Diagnostics and Pharmaceuticals White Paper: DNA Sequencing Moves into Clinical Applications White Paper: Sequencing Market Benefits From High-Profile Projects The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives White Paper: Tests That Personalize Show Faster Revenue Growth Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition